PARIS, Feb 18- A patient with terminal heart failure is in "satisfactory condition" two months after becoming the first person to be fitted with Carmat's artificial heart which is designed to beat for several years, his hospital said.
*Seeking U.S. partners, cites J&J, Medtronic, St Jude, Edwards. The French company is also seeking a partner in the United States to enter the world's largest healthcare market, and is in contact with Johnson& Johnson, Medtronic, St Jude Medical and Edwards Lifesciences, Marcello Conviti said.
Take a look at some of Wednesday's midday movers:
Check out which companies are making headlines after the bell Wednesday:
It’s time for the Lightning Round. Cramer makes the call on viewer favorites.
--Abiomed Inc rescheduled second-quarter conference call to Nov. 1 at 8 am Eastern Time. --Accelrys Inc rescheduled third-quarter results to Oct. 31, after market. Its conference call will be held on Nov. 1, 9.30 am Eastern Time.
Cramer makes the call on viewer favorites.
Jim Cramer makes the call on viewers' favorite stocks.
Michael Minogue discusses his company's earnings beat with Cramer.
Medical device maker, Abiomed's CEO, Michael Minogue, discusses his company's earnings beat, and whether the ultra expensive stock, selling for 5.8 times next year's sales, still has room to run, with Mad Money's Jim Cramer.
It's time for some "Mad Mail!" Get Cramer's calls on Universal Display, Abiomed and more.
A week ago, Michelle Leder at Footnoted, a Morningstar site, put out her Top 10 list based on the kinds of things she looks at in regulatory filings.
Cramer makes the call on viewers' favorite stocks.